The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...
The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an investigation, the agency stated ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
The agency issued a request for more information that will shape new regulation on ingredient transparency.
The U.S. Food and Drug Administration (FDA) is taking active steps to improve disclosure of gluten ingredients in foods.
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results